Cargando…

Galectin-1-mediated high NCAPG expression correlates with poor prognosis in gastric cancer

Galectin-1 (Gal1) and non-SMC condensin I complex, subunit G (NCAPG) are associated with metastasis in several malignant tumors. However, their precise roles in gastric cancer (GC) remain uncertain. This study explored the clinical significance and relationship of Gal1 and NCAPG in GC. Gal1 and NCAP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Tingrui, Qian, Tao, Zhou, Haihua, Cheng, Zhiyi, Liu, Guiyuan, Huang, Chuanjiang, Dou, Rongrong, Liu, Fuxing, You, Xiaolan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333058/ https://www.ncbi.nlm.nih.gov/pubmed/37335105 http://dx.doi.org/10.18632/aging.204806

Ejemplares similares

Galectin-1 promotes gastric cancer peritoneal metastasis through peritoneal fibrosis
por: Shen, Xianhe, et al.
Publicado: (2023)

Fibroblastic galectin-1-fostered invasion and metastasis are mediated by TGF-β1-induced epithelial-mesenchymal transition in gastric cancer
por: You, Xiaolan, et al.
Publicado: (2021)

Galectin-1 promotes vasculogenic mimicry in gastric adenocarcinoma via the Hedgehog/GLI signaling pathway
por: You, Xiaolan, et al.
Publicado: (2020)

Efficacy of DC-CIK Immunotherapy Combined with Chemotherapy on Locally Advanced Gastric Cancer
por: Liu, Guiyuan, et al.
Publicado: (2022)

Duodenal-Distal Ileal Fistula After Laparoscopic Radical Right Hemicolectomy: A Case Report
por: You, Xiaolan, et al.
Publicado: (2022)

Aberrant Expression of NCAPG is Associated with Prognosis and Progression of Gastric Cancer
por: Sun, Ding-Ping, et al.
Publicado: (2020)

Elevated mRNA Expression Levels of NCAPG are Associated with Poor Prognosis in Ovarian Cancer
por: Xu, Tao, et al.
Publicado: (2020)

KLF5 activates lncRNA DANCR and inhibits cancer cell autophagy accelerating gastric cancer progression
por: Cheng, Zhiyi, et al.
Publicado: (2021)

NCAPG2 promotes tumour proliferation by regulating G2/M phase and associates with poor prognosis in lung adenocarcinoma
por: Zhan, Ping, et al.
Publicado: (2016)

Upregulation of circRNA_100395 sponges miR-142-3p to inhibit gastric cancer progression by targeting the PI3K/AKT axis
por: Cheng, Zhiyi, et al.
Publicado: (2021)

Increased expression of NCAPG (Non-SMC condensing I complex subunit G) is associated with progression and poor prognosis of lung adenocarcinoma
por: Wang, Xiaodong, et al.
Publicado: (2022)

AC099850.3/NCAPG Axis Predicts Poor Prognosis and is Associated with Resistance to EGFR Tyrosine-Kinase Inhibitors in Lung Adenocarcinoma
por: Bao, Jiaqi, et al.
Publicado: (2022)

NCAPG as a Novel Prognostic Biomarker in Glioma
por: Jiang, Xiulin, et al.
Publicado: (2022)

PLAG1 and NCAPG‐LCORL in livestock
por: Takasuga, Akiko
Publicado: (2016)

NCAPG upregulation mediated by four microRNAs combined with activation of the p53 signaling pathway is a predictor of poor prognosis in patients with breast cancer
por: Dong, Menglu, et al.
Publicado: (2021)

Decreased Galectin-9 and Increased Tim-3 Expression Are Related to Poor Prognosis in Gastric Cancer
por: Jiang, Jing, et al.
Publicado: (2013)

Prognostic significance of galectin-1 and vasculogenic mimicry in patients with gastric cancer
por: You, Xiaolan, et al.
Publicado: (2018)

Reduced Expression of PTPRD Correlates with Poor Prognosis in Gastric Adenocarcinoma
por: Wang, Dandan, et al.
Publicado: (2014)

Galectin-1 Promotes Vasculogenic Mimicry in Gastric Cancer by Upregulating EMT Signaling
por: You, Xiaolan, et al.
Publicado: (2019)

FOXM1/lncRNA TYMSOS/miR-214-3p–Mediated High Expression of NCAPG Correlates With Poor Prognosis and Cell Proliferation in Non–Small Cell Lung Carcinoma
por: Yuan, Yixiao, et al.
Publicado: (2022)

NCAPG stimulates lung adenocarcinoma cell stemness through aerobic glycolysis
por: Zhang, Zuwang, et al.
Publicado: (2023)

GPR116 overexpression correlates with poor prognosis in gastric cancer
por: Zheng, Tian, et al.
Publicado: (2021)

NCAPG Promotes Tumor Progression and Modulates Immune Cell Infiltration in Glioma
por: Zheng, Guangrong, et al.
Publicado: (2022)

NCAPG Promotes The Proliferation Of Hepatocellular Carcinoma Through PI3K/AKT Signaling
por: Gong, Chengwu, et al.
Publicado: (2019)

The predictive value of galectin-1 and vascular mimicry in the prognostic evaluation of patients with rectal cancer
por: Zhou, Haihua, et al.
Publicado: (2021)

BASP1 expression is associated with poor prognosis and is correlated with immune infiltration in gastric cancer
por: Wang, Tao, et al.
Publicado: (2023)

Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma
por: Jiang, Shan-Shan, et al.
Publicado: (2014)

Overexpression of ezrin and galectin-3 as predictors of poor prognosis of cervical cancer
por: Li, M., et al.
Publicado: (2017)

Galectin-3 Expression in Colorectal Cancer and its Correlation with Clinical Pathological Characteristics and Prognosis
por: Tao, Liu, et al.
Publicado: (2017)

NCAPG Dynamically Coordinates the Myogenesis of Fetal Bovine Tissue by Adjusting Chromatin Accessibility
por: Hu, Xin, et al.
Publicado: (2020)

NCAPG2 Maintains Cancer Stemness and Promotes Erlotinib Resistance in Lung Adenocarcinoma
por: Jiang, Shiyao, et al.
Publicado: (2022)

CREM Is Correlated With Immune-Suppressive Microenvironment and Predicts Poor Prognosis in Gastric Adenocarcinoma
por: Yu, Kuai, et al.
Publicado: (2021)

NCAPG Is a Promising Therapeutic Target Across Different Tumor Types
por: Xiao, Cuicui, et al.
Publicado: (2020)

Characterizing the Crosstalk of NCAPG with Tumor Microenvironment and Tumor Stemness in Stomach Adenocarcinoma
por: Xiang, Zheng, et al.
Publicado: (2022)

Pan-cancer analysis of the immune aspects and prognostic value of NCAPG2
por: Feng, Huidong, et al.
Publicado: (2023)

Galectin-3 and β-catenin are associated with a poor prognosis in serous epithelial ovarian cancer
por: Liu, Yunyun, et al.
Publicado: (2018)

MicroRNA‑181c suppresses growth and metastasis of hepatocellular carcinoma by modulating NCAPG
por: Ai, Jiyuan, et al.
Publicado: (2019)

Galectin-3 not Galectin-9 as a candidate prognosis marker for hepatocellular carcinoma
por: Kong, Fei, et al.
Publicado: (2020)

Serum galectin-3 levels predict poor prognosis in sepsis and septic shock patients
por: Karabacak, Pınar
Publicado: (2023)

Decreased Levels of Active SMAD2 Correlate with Poor Prognosis in Gastric Cancer
por: Wu, Yijun, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_eaicnphj174pg41bojh5qtd6n3